AKT1 and esophageal cancer: In our present study, the results were shown that lncRNA LINC00152 knock-down could inhibit EGFR/PI3K/AKT pathway and stimulate P21 expression in esophageal cancer cell lines (Eca 109 and Kyse 150) in vitro study.